John A Orwin
Director · 9 filings · Latest: Sep 15, 2026
ANAPTYSBIO, INC
First Tracks Biotherapeutics, Inc.
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ANAB | John A Orwin | Director | Sep 15, 2026 | Option Exercise | $0.00 | 1,300 | — | 17,995 | |
TRAX | John A Orwin | Director | Sep 15, 2026 | Option Exercise | $0.00 | 1,300 | — | 17,995 | |
TRAX | John A Orwin | Director | Jun 15, 2026 | Option Exercise | $0.00 | 6,030 | — | 16,695 | |
ANAB | John A Orwin | Director | Jun 15, 2026 | Option Exercise | $0.00 | 6,030 | — | 16,695 |